Cargando…

Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features

OBJECTIVE: To determine the clinicopathological features of levodopa or dopamine agonist (DA) responders with multiple system atrophy (MSA), an autopsy-confirmed diagnosis is vital due to concomitant cases of MSA and Parkinson's disease (PD). We therefore aimed to investigate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Chiho, Takahashi, Kazuya, Kato-Motozaki, Yuko, Tagami, Atsuro, Komai, Kiyonobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925269/ https://www.ncbi.nlm.nih.gov/pubmed/32963152 http://dx.doi.org/10.2169/internalmedicine.4836-20

Ejemplares similares

Aspiration pneumonia and bronchopneumonia in progressive supranuclear palsy treated with qing fei tang: two case reports
por: Nozaki, Ichiro, et al.
Publicado: (2015)

Difference in the Care of Patients with Amyotrophic Lateral Sclerosis With and Without Intervention from the Palliative Care Team: Observations from a Center in Japan
por: Takahashi, Kazuya, et al.
Publicado: (2021)

Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease
por: Koga, Shunsuke, et al.
Publicado: (2020)

Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study
por: Tamura, Mitsuyoshi, et al.
Publicado: (2023)

Multiple system atrophy: clinicopathological characteristics in Japanese patients
por: OZAWA, Tetsutaro, et al.
Publicado: (2017)

Clinicopathological correlates of pyramidal signs in multiple system atrophy
por: Lin, Chi‐Ying R., et al.
Publicado: (2022)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis
por: Watanabe, Hirohisa, et al.
Publicado: (2018)

Changes in clinical features of multiple system atrophy in Japan
por: Tokuhara, Yusuke, et al.
Publicado: (2020)

Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2018)

Association of the prefrailty with global brain atrophy and white matter lesions among cognitively unimpaired older adults: the Nakajima study
por: Noguchi-Shinohara, Moeko, et al.
Publicado: (2022)

Variants associated with Gaucher disease in multiple system atrophy
por: Mitsui, Jun, et al.
Publicado: (2015)

Multiple system atrophy
por: Goh, Yee Yen, et al.
Publicado: (2023)

Thrombocytopenia Associated with Levodopa Treatment
por: Lee, Ku-Eun, et al.
Publicado: (2013)

Levodopa-Associated Barking Vocalizations
por: Prasad, Shweta, et al.
Publicado: (2021)

Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management
por: Pandey, Sanjay, et al.
Publicado: (2017)

Clinicopathologic Findings in Three Siblings With Geographic Atrophy
por: Edwards, Malia M., et al.
Publicado: (2023)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
por: Lee, Sang-Wook, et al.
Publicado: (2012)

Distinctive Features of NREM Parasomnia Behaviors in Parkinson’s Disease and Multiple System Atrophy
por: Ratti, Pietro-Luca, et al.
Publicado: (2015)

Models of multiple system atrophy
por: Lee, He-Jin, et al.
Publicado: (2019)

Bereitschaftspotential in Multiple System Atrophy
por: Yang, Yi-Chien, et al.
Publicado: (2021)

Inflammation in multiple system atrophy
por: Leńska-Mieciek, Marta, et al.
Publicado: (2023)

Parkinson's Disease: General Features, Effects of Levodopa Treatment and Future Directions
por: Freire, Marco Aurélio M., et al.
Publicado: (2010)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease
por: Guridi, J., et al.
Publicado: (2012)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Altered Brain Volume, Microstructure Metrics and Functional Connectivity Features in Multiple System Atrophy
por: Ge, Yunxiang, et al.
Publicado: (2022)

Opsoclonus-myoclonus syndrome associated with multiple system atrophy
por: Shindo, Kazumasa, et al.
Publicado: (2014)

Comparison of the endocytoscopic and clinicopathologic features of colorectal neoplasms
por: Takeda, Kenichi, et al.
Publicado: (2016)

Levodopa-Induced Pseudopheochromocytoma
por: Cardoso, Joana, et al.
Publicado: (2023)

Clinicopathological Features of Telbivudine-Associated Myopathy
por: Ambang, Tomica, et al.
Publicado: (2016)

Psychotic symptoms in the context of levodopa treatment in Parkinson’s Disease: clinical feature or iatrogenesis?
por: Costa, M.L., et al.
Publicado: (2022)

Gastric hamartomatous inverted polyp: Report of three cases with a review of the endoscopic and clinicopathological features
por: Ohtsu, Takuya, et al.
Publicado: (2023)

Genomic copy number variation analysis in multiple system atrophy
por: Hama, Yuka, et al.
Publicado: (2017)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Multiple System Atrophy: Genetic or Epigenetic?
por: Sturm, Edith, et al.
Publicado: (2014)

First symptoms in multiple system atrophy
por: McKay, Jake H., et al.
Publicado: (2018)

Diagnostic challenges in multiple system atrophy
por: Obelieniene, Diana, et al.
Publicado: (2018)

A case of multiple system atrophy
por: Guo, Jing, et al.
Publicado: (2019)

Multiple system atrophy with hippocampal pathology
por: Jellinger, Kurt A.
Publicado: (2022)

Freezing of Gait in Multiple System Atrophy
por: Yang, Huaguang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62rtoni7be1ruefl06r4p66h38